Connect with us

Technology

Unipart Group Announces the Appointment of Dr Bryan Jackson CBE as Non-Executive Chair

Published

on

OXFORD, England , Aug. 16, 2024 /PRNewswire/ — Unipart is pleased to announce the appointment of Dr Bryan Jackson CBE to the role of Non-Executive Chair from 1st September 2024. This follows the announcement on 14th August 2024 that Unipart’s Founder and Executive Chairman, Dr John M. Neill CBE, will retire from his position effective 31st August and will continue to support the business until the end of November.

Bryan has a long association with Unipart, commencing in 2005 with his appointment as Deputy Chairman of the Unipart Manufacturing Group. He joined the Board as an independent Non-Executive Director in April 2013 and was appointed Senior Independent Director in November 2022.

Bryan built an extensive career in automotive and manufacturing, beginning his career with the Ford Motor Company where he spent 23 years before joining Toyota Motor Manufacturing (UK) Limited in 1990. He has worked across many disciplines, holding senior positions and managing several plants in the UK and Europe covering the full range of vehicle manufacturing. He retired as Managing Director in 2004 and was an advisor to Toyota in Europe until 2009.

Bryan has significant Board-level experience gained across a variety of industries. Previous Board roles include being Chairman of Sharing in Growth UK Limited, Wesleyan Assurance Society, the Royal Orthopaedic Hospital NHS Foundation Trust, the East Midlands Development Agency (a government appointment) and the East Midlands Regional Council of the Confederation of British Industry. He is currently Non-Executive Chairman of John Smedley Limited.

He was awarded an honorary doctorate in business administration from Nottingham Trent University in recognition of his contribution as an industrialist and champion of economic growth. Bryan is a Fellow of the Manufacturing Technology Centre. He also attended executive development programmes at INSEAD Business School, Fontainebleau and Wharton Business School, University of Pennsylvania.

In 2000, Bryan was awarded an OBE for services to the motor manufacturing industry and in 2012, he was awarded a CBE for services to economic development and manufacturing.  

 John Neill, Unipart Executive Chairman said:

“Unipart is an iconic British company, and its next Chair required someone who not only understands the culture that has been meticulously crafted over the past 50 years, but someone whose personal values and integrity are aligned with Unipart.   

“I have had the privilege of knowing and working closely with Bryan for many decades, during which he has held several non-executive roles within the Unipart Group and added immense value through his expertise and leadership. My priority was to ensure that the Board approved a leader whom all our stakeholders can trust – someone who will consistently prioritise the well-being of Unipart, its people, and its customers above any personal interests. 

“I am confident that Bryan, who has exemplified this ethos in the past and was therefore an unrivalled candidate based on his extensive experience and commitment to Unipart, will continue to do so in the future. I wish Bryan, the Board and all our colleagues and leaders the very best for Unipart’s continued success.”

Bryan Jackson, Senior Independent Non-Executive Director said: 

“I am extremely proud to be appointed Chair of Unipart. How do you replace an iconic leader and the creator of this unique, highly-successful great British company? Luckily I have had the privilege of working with John over many years and I am honoured to take on this role and the responsibility of ensuring that the culture he created will continue, and to build on Unipart’s success to date in the future.

“I believe Unipart has strong growth prospects thanks to the solid, diversified business we have that has been built over the past 50 years of tireless commitment and dedication. I am looking forward to working with our people, customers, shareholders and stakeholders on our journey ahead.

“I would like to thank John again for everything he has done and wish him all the best for his future. While it will be incredibly difficult to follow in John’s footsteps, I am fully committed to working with the Board, leadership team and colleagues to drive Unipart forward through its next stage of growth and look forward to the many opportunities ahead.”

Please access Bryan Jackson’s biography here.

For media enquiries or further information, please contact:
Alistair Drummond, Head of External Communications
T: +44(0)7771 798835
E: alistair.drummond@unipart.com

Photo: https://mma.prnewswire.com/media/2483616/Dr_Bryan_Jackson_CBE.jpg
Logo:  https://mma.prnewswire.com/media/2382356/4856219/Unipart_Logo.jpg

 

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/unipart-group-announces-the-appointment-of-dr-bryan-jackson-cbe-as-non-executive-chair-302224214.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Quarterhill Awarded High-Speed Weigh-In-Motion Prescreening Contract in Belgium

Published

on

By

The new WIM station will assist Brussels Mobility in achieving its goals of improving road safety and creating a fair regulatory environment by reducing the number of overloaded vehicles on the roads of the Brussels region.Traffic data provided by the system will support Brussels Mobility’s mission to foster economic growth and improve quality of life through the development of transport infrastructure.

TORONTO, Jan. 10, 2025 /PRNewswire/ – Quarterhill Inc. (“Quarterhill” or the “Company”) (TSX: QTRH) (OTCQX: QTRHF), announced today a contract to provide weigh-in-motion (“WIM”) technology to Brussels Mobility through a joint project with Belgium-based technology integrator Jacops NV (“Jacops”). Quarterhill will be responsible for the design and supply of the WIM subsystem, technical support, and training. Quarterhill will also provide Jacops with the software necessary for commercial vehicle monitoring and enforcement.

Quarterhill will supply the WIM system for the Brussels-Capital Region weigh station, which will be used to pre-select overloaded vehicles for enforcement. The dynamic weighing station will promote and improve the efficiency of inspections by screening vehicles at highway speeds in advance of the law enforcement inspection site. In addition, the weigh station will generate data that provides an accurate, real-time picture of the vehicles on the E19 highway.

The system’s goal is to reduce the number of overloaded vehicles on the Brussels Region’s roads. Overloading causes many problems, such as rapid road deterioration, more serious accidents, and unfair competition between transport companies. Quarterhill’s technology mitigates these issues by screening for overweight vehicles while optimizing the use of enforcement resources.

“We are excited at the prospect of introducing our advanced enforcement technology to Brussels Mobility and expanding our presence in Europe,” said Chuck Myers, CEO of Quarterhill. “Together with Jacops, we will deploy a state-of-the-art high-speed WIM system that will make Belgian roads safer and more sustainable. We have a longstanding relationship with Jacops as a customer for our microwave sensor products, and this project demonstrates how having a broad portfolio of traffic technologies and established relationships with traffic system integrators leads to further opportunities.”

The weigh station will monitor four lanes of one-way traffic on the highway and record data on vehicle classification and vehicle tax without impeding traffic. An overview camera provides images to help enforcement personnel clearly identify vehicles flagged by the system. An Automated Number Plate Reader system will photograph, recognize, store, process, and transmit the number plates of vehicles approaching the dynamic weighing station.

Quarterhill’s iSINC WIM controller was selected for the project as it offers preselection of overweight vehicles, creates comprehensive vehicle records, classifies vehicles, and meets the desired standards for continual uptime monitoring and ease of service. iSINC’s versatility allows it to control a wide array of sensors, cameras, dimensioning systems, communication systems, and custom equipment.

WIM sensors that comply with the accuracies outlined in the Nmi International WIM standard Specification and test procedures for WIM Systems will be installed at the site. The WIM sensors meet the lane width specifications and provide high durability, stable output over time, and IP68 water resistance.

Quarterhill will advise Jacops on the design and placement of the WIM system components to ensure optimal operation, including onsite technical support for installation, testing, and initial calibration. Quarterhill will also provide Jacops with thorough training on the WIM components and system calibration. Over the 2-year warranty period, Quarterhill will provide remote diagnostics and technical support to ensure continuous uptime and optimal performance.

“This project shows that Quarterhill’s technology is well suited to the precise needs of European agencies. We are set to elevate road safety and integrity in the region, reinforcing our expanding footprint in this important market,” stated Heimo Haub, Managing Director, Quarterhill Europe.

About Quarterhill
Quarterhill is a leading provider of tolling and enforcement solutions in the Intelligent Transportation System (ITS) industry. Our goal is technology-driven global leadership in ITS, via organic growth of our tolling and enforcement businesses, and by continuing an acquisition-oriented investment strategy that capitalizes on attractive growth opportunities within ITS and its adjacent markets. Quarterhill is listed on the TSX under the symbol QTRH and on the OTCQX Best Market under the symbol QTRHF. For more information: www.quarterhill.com.

Forward-looking Information
This news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). Such forward-looking statements relate to future events, conditions or future financial performance of ‎Quarterhill based on future economic conditions and courses of action. All statements other ‎than statements of historical fact may be forward-looking statements. Such forward-looking statements ‎are often, but not always, identified by the use of any words such as “seek”, “anticipate”, “budget”, ‎‎”plan”, “goal”, “expect” and similar expressions.

Forward-looking statements involve known and unknown risks, assumptions, ‎uncertainties and other factors that may cause actual results or events to differ materially from those ‎anticipated in such forward-looking statements. Material risk factors that could cause actual results to differ materially from the forward-looking statements contained in this news release include, among others, demand for Quarterhill’s products and services; general economic and market conditions; competition; risks relating to technological advances and cyber-security; and other risks set forth in the Company’s most recent annual information form available on SEDAR+ at www.sedarplus.ca. The Company believes the expectations reflected in ‎the forward-looking statements are reasonable, but no assurance can be given that these expectations ‎will prove to be correct and such forward-looking statements included in this news release should not be ‎unduly relied upon.‎ Material factors and assumptions used to develop the forward-looking statements contained in this news release include, among others: Quarterhill’s ability to execute on its business plan; demand for Quarterhill’s products and services; operating assumptions; and financial projections and cost estimates. Quarterhill has no intention, and undertakes no obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

View original content:https://www.prnewswire.com/news-releases/quarterhill-awarded-high-speed-weigh-in-motion-prescreening-contract-in-belgium-302347610.html

SOURCE Quarterhill

Continue Reading

Technology

ez1099 2024 Edition Tax Preparation Software for 2025 Tax Season Is Available for Electronic Filing

Published

on

By

REDMOND, Wash., Jan. 10, 2025 /PRNewswire/ — Designed for US business owners, tax professionals and entrepreneurs, the latest ez1099 tax form software from Halfpricesoft.com is easy to navigate and streamline processing unlimited forms for multiple companies for one flat rate.  The latest edition of ez1099 supports paper form printing, pdf printing and efile feature. It also comes with a recipient data import feature from the spreadsheet and QuickBooks IIF file.

 

“ez1099 2024 software is now available for business owners and tax professionals to print and file 1098’s and 1099’s, seamlessly.” Dr. Ge, Founder of Halfpricesoft.com, says.

ez1099 software streamlines the preparation, printing, and e-filing of essential IRS forms, including W2G, 1097BTC, various 1098 forms (1098, 1098C, 1098E, 1098F, 1098Q, 1098T), numerous 1099 forms (1099A, 1099B, 1099C, 1099CAP, 1099DIV, 1099G, 1099INT, 1099K, 1099LTC, 1099MISC, 1099NEC, 1099OID, 1099PATR, 1099Q, 1099QA, 1099R, 1099S, 1099SB, 1099SA), 5498 forms (5498, 5498ESA, 5498QA, 5498SA), as well as 8935, 3921, 3922, and 1096 forms.

Cost is only $79 per installation for the basic version of ez1099 Software or $139 per installation for the advanced version with bulk printing feature, import feature, PDF file creation and electronic filing capability. Also offered in a network version for two or more installations starting at $199 to enable sharing data between computers or offices.

ez1099 is compatible with Windows 11, 10, and 8.  It can also run on Windows Vista system, 7, and MAC machines (Mac can run the system only if installed with Bootcamp).

The features in the latest version ez1099 software include but are not limited to:

electronically file unlimited forms to the IRS with one flat rateez1099 blank paper prints out recipient copiesPrint in bulk for faster processingQuick data importing featureCustomers can save even more time by compiling and saving form data for later use and modificationSupport unlimited accounts and unlimited recipients at no additional chargeGo green with optional PDF document converting and e-file (electronic filing) featuresFeature to process correction forms included

Starting at $79.00 for the print and mail version and $139.00 to electronically file. Halfpricesoft.com welcomes all clients to begin the no obligation thirty-day test drive today at https://www.halfpricesoft.com/1099_software.asp#purchase

About halfpricesoft.com

Halfpricesoft.com is a leading provider of small to midsize business software, including online and desktop payroll software, online employee attendance tracking software, accounting software, in-house business and personal check printing software, W2, software, 1099 software, 1095 ACA form software and ezACH direct deposit software. Software from halfpricesoft.com is trusted by thousands of customers for over 20 years and will assist business owners simplify payroll processing and streamline business management.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ez1099-2024-edition-tax-preparation-software-for-2025-tax-season-is-available-for-electronic-filing-302340859.html

SOURCE Halfpricesoft.com

Continue Reading

Technology

The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease

Published

on

By

Partnership Will Harness NYSCF’s Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level

NEW YORK, Jan. 10, 2025 /PRNewswire/ — The New York Stem Cell Foundation (NYSCF) Research Institute today announced they have entered into an agreement with Janssen Research & Development, LLC, a Johnson & Johnson company, to use NYSCF’s AI-powered platform for drug discovery to target neurodegenerative disease. This initiative brings together NYSCF’s advanced robotic systems for stem cell research and J&J’s expertise in drug discovery and data science to unlock novel disease insights and accelerate the development of more effective and tailored treatments.

NYSCF has developed proprietary automation technology that enables large-scale, reproducible disease modeling and drug screening using patient-derived stem cells. By combining high-content cell imaging with machine learning-driven analysis, NYSCF’s platform can reveal previously undiscovered disease phenotypes and therapeutic targets leading to the development of novel therapeutic approaches. This versatile platform is adaptable to a wide range of cell types and diseases, making it uniquely positioned to advance precision medicine for patients.

“This work with Johnson & Johnson allows us to integrate our cutting-edge stem cell automation and AI platform with their deep expertise in therapeutic development,” said Jennifer J. Raab, President and CEO of NYSCF. “Together, we look forward to accelerating the discovery of innovative treatments for patients affected by devastating neurodegenerative disease.”

About The New York Stem Cell Foundation Research Institute
The New York Stem Cell Foundation (NYSCF) Research Institute is an independent non-profit organization accelerating cures and better treatments for patients through stem cell research. The NYSCF Research Institute is an acknowledged world leader in stem cell research and in the development of pioneering stem cell technologies, including the NYSCF Global Stem Cell Array®, which is used to create cell lines for laboratories around the globe. NYSCF focuses on translational research in an accelerator model designed to overcome barriers that slow discovery and replace silos with collaboration. For more information, visit nyscf.org.

CONTACTS:
David McKeon
212-365-7440
dmckeon@nyscf.org

Chris Taylor
chris@christaylorpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-new-york-stem-cell-foundation-research-institute-enters-agreement-to-accelerate-precision-drug-discovery-for-neurodegenerative-disease-302347569.html

SOURCE The New York Stem Cell Foundation

Continue Reading

Trending